SCHEMBL18017907

SCHEMBL18017907

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc(-c6cccc(-c7cccc(-c8nc(-c9ccc(-c%10ccccc%10)cc9)c9oc%10ccccc%10c9n8)c7)c6)c5)c4)c4sc5ccccc5c4n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.41
▸ ALDH1A1 P00352 9/20 0.41
▸ TSHR P16473 5/20 0.41
▸ POLB P06746 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.40
▸ KMT2A Q03164 8/20 0.39
▸ LMNA P02545 5/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ USP2 O75604 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MEN1 O00255 7/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ ALOX12 P18054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017977 1.00 MAPT (0.41) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017937 1.00 MAPT (0.41) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18018293 0.99 MAPT (0.42) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017975 0.99 MAPT (0.42) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017663 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017672 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017960 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017648 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017654 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E
SCHEMBL18017925 0.98 MAPT (0.43) MAPTALDH1A1TSHRPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OCIAD1 MAPT 2194/4885ALDH1A1 63/4885TSHR 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback